Vi 
Associate Professor Jod Mehta, a world-leading corneal specialist from Singapore National Eye Centre (SNEC), will work at FV Hospital on 29th and 30th September 2017 under the FVH Partnership Programme.
This is a great opportunity for patients with corneal conditions to receive consultation and treatment directly from A leading international specialist in Vietnam.
Assoc. Prof. Jod Mehta is recognised worldwide for his expertise in complicated corneal transplant techniques, including:
- Penetrating keratoplasty
- Anterior lamellar keratoplasty
- Endothelial keratoplasty
- Combining penetrating keratoplasty and cataract surgery
- Combining endothelial keratoplasty and cataract surgery
- Complicated anterior lamellar keratoplasty
- Complicated endothelial keratoplasty
In addition to providing consultations, Assoc. Prof. Jod Mehta will also give a presentation and answer questions during a public seminar on corneal conditions for Vietnamese people, held at FV Hospital.
Dr Mehta’s Working and public seminar schedule:
Clinic hours: from 13:00 to 17:00, 29th and 30th September 2017.
Contact: (028) 5411 3333, Ext. 2000
Public seminar schedule: 08:30 am, 30th September 2017.
Contact: 0962 627 847
Assoc. Prof. Jod Mehta graduated from St Thomas’s Medical School, University of London, UK, in 1995. He completed his basic and advanced specialist training in cornea external disease and refractive surgery at Moorfields Eye Hospital (UK) and Singapore National Eye Centre, where he was invited to work until now.
Assoc. Prof Mehta is a member of the Royal College of Ophthalmologists in the UK, the American Academy of Ophthalmology, the Singapore-Malaysian Ophthalmology Society and the Asian Corneal Society. He has won 24 awards in the UK and around the world for his clinical and research work.
At SNEC, his work is mainly in corneal transplantation, anterior segment reconstruction and in refractive surgery.
Assoc. Prof. Mehta’s research covers new stem-cell-based therapies, development of an artificial cornea device, new instruments for corneal transplantation, femtosecond lasers in corneal/refractive surgery and development of novel drug delivery devices.
